Clinical Trials in Neurology
- Advances in Clinical Trial Design and Methodology
- Drug Development and Emerging Therapies
- Biomarkers in Clinical Trials
- Gene Therapy and Cell Therapy Trials
- Ethical, Regulatory, and Practical Challenges in Neurological Clinical Trials
Clinical Trials in Neurology are essential for developing new treatments, drugs, and medical interventions to improve outcomes for patients with neurological disorders. This session will explore the latest clinical research, focusing on ongoing and completed trials for conditions such as Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, epilepsy, stroke, neuromuscular disorders, and neuropsychiatric conditions. Key discussions will cover trial design, patient recruitment challenges, regulatory hurdles, and ethical considerations in conducting neurological clinical trials.
Advancements in biomarkers, artificial intelligence (AI), neuroimaging, and real-world evidence (RWE) are transforming how clinical trials are conducted, improving the accuracy of diagnosis, disease progression monitoring, and treatment response evaluation. The session will highlight emerging therapies, including gene therapy, stem cell treatments, immunotherapy, neuromodulation techniques, and targeted pharmacological interventions, showcasing their potential to revolutionize neurological care. Additionally, discussions will focus on innovative trial methodologies, such as adaptive trial designs, placebo-controlled studies, and decentralized clinical trials, which are enhancing trial efficiency and patient accessibility.
By bringing together neurologists, clinical researchers, pharmaceutical experts, and regulatory professionals, this session aims to foster collaboration, address key challenges in neurological clinical trials, and accelerate the development of safe and effective therapies. As clinical research continues to evolve, integrating precision medicine, patient-centered approaches, and data-driven insights will be crucial in shaping the future of neurology and neuroscience.
